Main page content

Displaying results 21 - 29 of 29
Publication ID: SMA15-4927
Published:

This NSDUH report discusses trends in the prevalence of mental illness, substance use disorders, or both among adolescents and adults in the United States.

Publication ID: SMA15-4442
Published:

This brochure informs patients about buprenorphine and medication-assisted treatment for opioid use disorder. It describes addiction and withdrawal, how buprenorphine works, its proper use, its side effects, and how it fits with counseling in the recovery process.

Publication ID: SMA14-4854
Published:

This report presents information about Medicaid coverage of medication-assisted treatment for opioid and alcohol dependence. It covers treatment effectiveness and cost effectiveness. The report also offers examples of innovative approaches in Vermont, Massachusetts, and Maryland.

Publication ID: SMA14-4852
Published:

This guide highlights the use of medication-assisted treatment (MAT) for opioid use disorder in drug courts. It reviews effective medications, including methadone, buprenorphine, and naltrexone. The guide also provides strategies to increase the use of MAT in drug court programs.

Publication ID: PEP14-MAYORSRG
Published:

This resource guide equips mayors and other local public health officials with strategies and resources to shape community responses that promote mental health and substance use disorder recovery, and ensure that needed treatments and services are available.

Publication ID: SMA11-4442VIETNAMESE
Published:

Gives patients information on buprenorphine and medication-assisted treatment for opioid addiction. Describes addiction and withdrawal, how buprenorphine works, its proper use, its side effects, and how it fits with counseling in the recovery process.

Publication ID: SMA12-4724
Published:

This report presents the key principles and core expectations of the State Epidemiological Outcomes Workgroups. The workgroups are designed to use data to inform and enhance state and community decisions regarding substance use and mental illness prevention programs.

Publication ID: SMA15-4442SPANISH
Published:

Esta hoja de hechos ofrece informacion a los pacientes sobre la buprenorfina y los tratamientos con ayuda de medicamentos para tratar el trastorno por uso de opioides, y tambien describe el mal uso y los sintomas del sindrome de abstinencia. Explica como funciona la buprenorfina, su uso apropiado, sus efectos secundarios y como se la utiliza en conjunto con al consejeria en el proceso de recuperacion.

Publication ID: SMA10-4557
Published:

This manual offers guidance on creating a substance use specialist program in child welfare offices or dependency courts. It includes case studies that showcase the programmatic and collaborative structure of substance use specialist programs.

Displaying 21 - 29 out of 29